Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000406394

Medchemexpress LLC Betaxolol hydrochloride | 63659-19-8 | 98.1% | 50 MG
SDP

Catalog No. 5000406394
Encompass_Preferred

Betaxolol hydrochloride is a selective beta1 adrenergic receptor blocker used in research for hypertension and glaucoma. It is a cardioselective beta-adrenergic receptor blocking agent. Studies have shown that it can diminish anxiety-like behavior during early withdrawal from chronic cocaine administration in rats. It may also be safer for patients with reactive airway disease compared to timolol or levobunolol due to less systemic beta 2- and possibly beta 1-adrenergic receptor blockade.

Features:

  • Selective beta1 adrenergic receptor blocker
  • Used for research of hypertension and glaucoma
  • Cardioselective beta-adrenergic receptor blocking agent
  • Diminishes anxiety-like behavior during early withdrawal from chronic cocaine administration in rats
  • May be safer for patients with reactive airway disease

Catalog No. 50-004-06394 Supplier Medchemexpress LLC Supplier No. HYB0381A50MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Betaxolol hydrochloride is a selective beta1 adrenergic receptor blocker used in research for hypertension and glaucoma. It is a cardioselective beta-adrenergic receptor blocking agent. Studies have shown that it can diminish anxiety-like behavior during early withdrawal from chronic cocaine administration in rats. It may also be safer for patients with reactive airway disease compared to timolol or levobunolol due to less systemic beta 2- and possibly beta 1-adrenergic receptor blockade.

Features:

  • Selective beta1 adrenergic receptor blocker
  • Used for research of hypertension and glaucoma
  • Cardioselective beta-adrenergic receptor blocking agent
  • Diminishes anxiety-like behavior during early withdrawal from chronic cocaine administration in rats
  • May be safer for patients with reactive airway disease

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.